These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 715450
1. Memory impairment in Korsakoff's psychosis: a correlation with brain noradrenergic activity. McEntee WJ, Mair RG. Science; 1978 Nov 24; 202(4370):905-7. PubMed ID: 715450 [Abstract] [Full Text] [Related]
2. Monoamine activity correlates with psychometric deficits in Korsakoff's disease. Mair RG, McEntee WJ, Zatorre RJ. Behav Brain Res; 1985 May 24; 15(3):247-54. PubMed ID: 2408635 [Abstract] [Full Text] [Related]
3. Neurochemical pathology in Korsakoff's psychosis: implications for other cognitive disorders. McEntee WJ, Mair RG, Langlais PJ. Neurology; 1984 May 24; 34(5):648-52. PubMed ID: 6200802 [Abstract] [Full Text] [Related]
4. Central nervous system catecholamine metabolism in Korsakoff's psychosis. Martin PR, Weingartner H, Gordon EK, Burns RS, Linnoila M, Kopin IJ, Ebert MH. Ann Neurol; 1984 Feb 24; 15(2):184-7. PubMed ID: 6200058 [Abstract] [Full Text] [Related]
9. Neurochemical specificity of learning: dopamine and motor learning. McEntee WJ, Mair RG, Langlais PJ. Yale J Biol Med; 1987 Feb 24; 60(2):187-93. PubMed ID: 2437709 [Abstract] [Full Text] [Related]
10. Central noradrenergic function in man: vanillylmandelic acid in CSF. Jimerson DC, Gordon EK, Post RM, Goodwin FK. Brain Res; 1975 Dec 05; 99(2):434-9. PubMed ID: 1182564 [No Abstract] [Full Text] [Related]
11. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state. Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S. Biol Psychiatry; 1983 Oct 05; 18(10):1141-52. PubMed ID: 6197099 [Abstract] [Full Text] [Related]
12. Origins of catecholamine metabolites in monkey cerebrospinal fluid. Gordon E, Perlow M, Oliver J, Ebert M, Kopin I. J Neurochem; 1975 Sep 05; 25(3):347-9. PubMed ID: 808591 [No Abstract] [Full Text] [Related]
13. The circadian pattern of catcholamine metabolites and cAMP in the cerebrospinal fluid of subhuman primates. Perlow M, Gordon E, Ebert M, Festoff B, Chase TN. Trans Am Neurol Assoc; 1976 Sep 05; 101():279-80. PubMed ID: 195383 [No Abstract] [Full Text] [Related]
15. CSF monoamine metabolites in mania. Swann AC, Secunda S, Davis JM, Robins E, Hanin I, Koslow SH, Maas JW. Am J Psychiatry; 1983 Apr 05; 140(4):396-400. PubMed ID: 6188381 [Abstract] [Full Text] [Related]
16. Reduced lumbar CSF somatostatin levels in Alzheimer's disease. Wood PL, Etienne P, Lal S, Gauthier S, Cajal S, Nair NP. Life Sci; 1982 Nov 08; 31(19):2073-9. PubMed ID: 6184590 [No Abstract] [Full Text] [Related]
17. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies. Garelis E, Young SN, Lal S, Sourkes TL. Brain Res; 1974 Oct 11; 79(1):1-8. PubMed ID: 4279131 [No Abstract] [Full Text] [Related]
18. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. Palmer AM, Sims NR, Bowen DM, Neary D, Palo J, Wikstrom J, Davison AN. J Neurol Neurosurg Psychiatry; 1984 May 11; 47(5):481-4. PubMed ID: 6204017 [Abstract] [Full Text] [Related]
19. Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism. Stern Y, Mayeux R, Côté L. Arch Neurol; 1984 Oct 11; 41(10):1086-9. PubMed ID: 6206831 [Abstract] [Full Text] [Related]
20. Childhood psychosis and monoamine metabolites in spinal fluid. Gillberg C, Svennerholm L, Hamilton-Hellberg C. J Autism Dev Disord; 1983 Dec 11; 13(4):383-96. PubMed ID: 6198318 [Abstract] [Full Text] [Related] Page: [Next] [New Search]